COX-2 inhibition and thrombotic tendency: A need for surveillance

Medical Journal of Australia

Volumn 175, Issue 4, 2001, Pages 214-217

  Cleland, L G ^a   James, M J ^a   Stamp, L K ^a   Penglis, P S ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ENOXAPARIN; FOLIC ACID; IBUPROFEN; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ROFECOXIB; WARFARIN;

ANTIINFLAMMATORY ACTIVITY; ARTERY THROMBOSIS; ARTHROPATHY; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG EFFICACY; DRUG MARKETING; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; GASTROINTESTINAL SYMPTOM; HEART PROTECTION; HUMAN; REVIEW; STOMACH PROTECTION; THROMBOSIS; VEIN THROMBOSIS;

EID: 0035920869     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143099.x     Document Type: Review

References (17)

1. COX-2 inhibitors
2. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners
3. Cyclooxygenase in biology and disease
4. Celecoxib, a COX-2-specific inhibitor: The clinical data
5. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
6. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
7. Effect of 50 mg enteric-coated aspirin (Astrix) on thromboxane and prostacyclin synthesis
8. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients
9. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
10. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study. A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
11. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases
12. Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding
13. Causes of death, Australia 1997
14. Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial
15. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
16. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART)
17. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease